Gymnastik- och idrottshögskolan, GIH

Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity
Karolinska Inst, Dept Oncol Pathol, CCK, R8 01, S-17176 Stockholm, Sweden.
Karolinska Inst, Karolinska Hosp Solna, Dept Clin Neurosci, CMM, S-17176 Stockholm, Sweden.
Karolinska Inst, Dept Oncol Pathol, CCK, R8 01, S-17176 Stockholm, Sweden.
Uppsala universitet, Science for Life Laboratory, SciLifeLab.
Visa övriga samt affilieringar
2018 (Engelska)Ingår i: iScience, E-ISSN 2589-0042, Vol. 9, s. 71-83Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

High-grade gliomas (HGGs) are the most aggressive and invasive primary brain tumors. The platelet-derived growth factor (PDGF) signaling pathway drives HGG progression, and enhanced expression of PDGF receptors (PDGFRs) is a well-established aberration in a subset of glioblastomas (GBMs). PDGFRA is expressed in glioma cells, whereas PDGFRB is mostly restricted to the glioma-associated stroma. Here we show that the spatial location of TAMMs correlates with the expansion of a subset of tumor cells that have acquired expression of PDGFRB in both mouse and human low-grade glioma and HCGs. Furthermore, M2-polarized microglia but not bone marrow (BM)-derived macrophages (BMDMs) induced PDGFRB expression in glioma cells and stimulated their migratory capacity. These findings illustrate a heterotypic cross-talk between microglia and glioma cells that may enhance the migratory and invasive capacity of the latter by inducing PDGFRB.

Ort, förlag, år, upplaga, sidor
2018. Vol. 9, s. 71-83
Nationell ämneskategori
Cell- och molekylärbiologi Cancer och onkologi
Identifikatorer
URN: urn:nbn:se:gih:diva-7942DOI: 10.1016/j.isci.2018.10.011ISI: 000454331400007PubMedID: 30384135OAI: oai:DiVA.org:gih-7942DiVA, id: diva2:1812657
Forskningsfinansiär
Cancerfonden, 2016/825Cancerfonden, CAN 2016/791Vetenskapsrådet, 2013-5982Barncancerfonden, NCP2015-0064Barncancerfonden, NC2014-0046Barncancerfonden, PR2014-0154WallenbergstiftelsernaTillgänglig från: 2023-11-16 Skapad: 2023-11-16 Senast uppdaterad: 2025-09-16

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedFulltext

Person

Bolin, SaraJiang, YiwenSwartling, Fredrik J.Uhrbom, Lene

Sök vidare i DiVA

Av författaren/redaktören
Bolin, SaraJiang, YiwenSwartling, Fredrik J.Uhrbom, Lene
I samma tidskrift
iScience
Cell- och molekylärbiologiCancer och onkologi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 166 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf